The Current State of Immunotherapy for Pancreatic Cancer

As of 2018, pancreatic cancer has been the third leading cause of cancer deaths in the United States. With the recent trend of the utility of immunotherapy against cancer, pancreatic cancer should have been another candidate for such treatment. However, complications arise within the nature of the disease. In this article, we will try to shed light on these complications and look into the present situation of immunotherapy for pancreatic cancer. We will discuss future possibilities and setbacks for this therapy, along with why researchers are now focusing on this treatment as the next beacon of hope for our pancreatic …read more